Clinical Trial Update: Safety Study of Topical Human FGF-1 for Wound Healing [Phase 1]

View source ↗

Summary

Phase 1 safety study of a topical fibroblast growth factor-1 (FGF-1) for wound healing in diabetic foot ulcers; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• Fibroblast growth factor-1, topical (Fibroblast growth factor-1)

Snippet

Sponsor: Phage Pharmaceuticals, Inc. | Conditions: Diabetic Foot Ulcers | Phase 1 | Status: UNKNOWN